Matt Alkaitis, MD PhD

Resident physician @StanfordMed, clin dev @biosignals, PM @google, via MD @HarvardMed, PhD @UniofOxford @NIH, Fellow @McKinsey and @FlagshipPioneer

[Josh Wolfe @wolfejosh]

@tomgara @gabecunn @kevg1412 @jasonzweigwsj @NeilThanedar 86/ Tim Bushe — hedge designer
#nominativedeterminism
(ht @MAlkaitis)

[Matt Alkaitis, MD PhD @MAlkaitis]

@wolfejosh @tomgara @gabecunn @kevg1412 @jasonzweigwsj @NeilThanedar @wolfejosh Tim Bushe - creative hedge trimmer

https://t.co/Fu6l6YcEDa

[CNS Summit @CNSSummit]

@Biosignals' @Jake_Donoghue shares how his company's EEG #neurobiomarker platform holds the potential to accelerate #clinicaltrials and ultimately enable new treatment options for #psychiatric diseases. #CNSSummit2023

[Amjad Masad @amasad]

If you don't have access to GPT-4, you can try it here for free: https://t.co/gtgMQFDYUI

[Matt Alkaitis, MD PhD @MAlkaitis]

@justinkarlin @OGdukeneurosurg Posterior INO of Lutz https://t.co/dlEgRCOqhn

[foobar/ @0xfoobar]

GPT-3 explains why DALL-E will never create true art

[Massimo @Rainmaker1973]

3D artist Jigar Patel (@jigpx) makes mesmerizing computer graphic animations. He created a series of brilliant clips called “Logo Factory”, and it's quite hard to stop looking at them

TikTok: https://t.co/23Dvr1CsRj
Instagram: https://t.co/GrGuT4bQey

[Paul Graham @paulg]

A really insightful (and bravely unconventional) essay by Brie Wolfson about the excitement of working hard.

https://t.co/LJvRIWNEdU

[Jacob Shea @JacobShea]

Since we're back to 2019 valuations, may as well bring back the #SaaS Funding Napkin via @chrija of @PointNineCap #vc

[Matt Alkaitis, MD PhD @MAlkaitis]

Might start pasting this at the bottom of my H&Ps

[Julian Shapiro @Julian]

Awesome visual of what people mean when they describe the likelihood of something:

Source: https://t.co/3uRMrawjiG

[Julie Yoo @julesyoo]

1/ The intersection of Healthcare x Fintech = a meaty zone in which to build. But where to start? What makes for a good play? What learnings from general fintech apply? Some thoughts from Team @a16z Healthcare x Fintech: https://t.co/LMIo0Ug0TR

[Matt Alkaitis, MD PhD @MAlkaitis]

Could not agree more. Under-appreciated that when we deprecate step 1 and remove clerkship grades, name brand becomes even more overweighted

[Roxana Daneshjou MD/PhD @RoxanaDaneshjou]

He would have been successful no matter where he chose to practice either in academics or the community (please don't take this to mean that one should be preferred). My larger message is that we should be focusing on finding good people, not just looking at school name brands.

[Matt Alkaitis, MD PhD @MAlkaitis]

@jfschneidr @biosignals cc:@jake__donoghue

Computational EEG for drug discovery, clinical trials and diagnostic applications

https://t.co/eC0ay4FSjw

[Alex Lieberman @businessbarista]

The three I just read:

7 types of angel investors: https://t.co/YGa81SN2cY

VC economics:
https://t.co/EGDmPvzEqd

Questions VCs will ask you:
https://t.co/DZhublK0xu

[Ronald Witteles @Ron_Witteles]

SO GREAT to be back in person for the Annual @StanfordMedRes Research Symposium! Incredible event, amazing turnout by residents/faculty, so much joy! 😀 Amazed by the incredible work of our residents every year. @AJRogers_ICU @HeartBobH @StanfordDeptMed @JoyYWu @StanfordChiefs

[Joy Wu, MD, PhD @JoyYWu]

The @StanfordMedRes Residency Research Symposium is an annual highlight @StanfordDeptMed. Congratulations to all the residents on their phenomenal research accomplishments! 👏🏻👏🏻

[Matt Alkaitis, MD PhD @MAlkaitis]

@chrissyfarr These situations exist because PBMs take a percentage cut of rebate and also protect rebate flows so they can competitively market to health plans. Unfortunately very few articles on pharma pricing fully explain this dynamic.

[Matt Alkaitis, MD PhD @MAlkaitis]

@chrissyfarr Important caveat to this framing: the 7k comes back as rebate *after* PBM/plan initially paid out 10k list price. Hurts patients with co-insurance based on list. Also hurts PR for pharma industry because public only sees list price and not the effective $3k net price.

[Justin Ouyang @justindouyang]

I spent the past decade of my career in sales strategy at @Slack, @Intercom @Zenefits and saw so many opportunities to apply the same tactics to #recruiting

But I don’t see most companies embracing this yet and it can give them an edge 🧵

[Jan-Felix Schneider @jfschneidr]

Who will be the @Plaid of health care?